ArticleThyroid research2022
Management of malignant struma ovarii: is aggressive therapy justified? Case report and literature review.
Article in Thyroid research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.
- Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review.Journal of the Egyptian National Cancer Institute · 2025Pooled it
- BenignOxford medical case reports · 2026Article
- Article
- Optimal Strategies for the Surgical and Long-Term Management of Malignant Struma Ovarii.Case reports in endocrinology · 2026Article
- A Case Report of Malignant Struma Ovarii With Papillary Thyroid Carcinoma.Clinical case reports · 2025Article
- Recurrent Malignant Struma Ovarii With Peritoneal Implants Following Prior Thyroid Carcinoma Treatment.Cureus · 2025Article
- Struma ovarii-diagnostic and treatment strategy: a case report.Journal of medical case reports · 2025Article
- A Challenging Diagnosis of Papillary Thyroid Carcinoma Arising From Malignant Struma Ovarii.Cureus · 2025Article
- Papillary thyroid carcinoma within struma ovarii: a case report and literature review.Journal of surgical case reports · 2025Article
- Malignant struma ovarii in pregnancy: A case report.Gynecologic oncology reports · 2024Article
- Monodermal teratoma: Three case reports and review of literature.World journal of clinical cases · 2024Article
- A case report of malignant struma ovarii with papillary thyroid carcinoma.Clinical case reports · 2024Article
- Struma Ovarii: Single Center Experience.Sisli Etfal Hastanesi tip bulteni · 2024Article
- Successful Management and Long-term Survival of Malignant Struma Ovarii with Radioactive Iodine Therapy.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, IndiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStruma ovarii (SO) is a rare ovarian teratoma containing predominantly thyroid tissue. In rare situations SO may develop malignancy. Most cases of malignant struma ovarii (MSO) are diagnosed after surgical removal, based on histopathological examination. There are still controversies regarding the extent of surgery and postoperative management in MSO, due to its unpredictable behavior, possible risk of metastasis and relatively high rate of recurrence. CASE PRESENTATION: We present the case of a patient diagnosed with a right ovarian cyst discovered incidentally during routine ultrasound examination. Its rapid growth and pelvic MRI raised the suspicion of a neoplastic process. She underwent total hysterectomy and bilateral adnexectomy. The anatomopathological diagnosis was MSO with follicular variant of papillary thyroid carcinoma. Prophylactic total thyroidectomy was performed, followed by radioactive iodine ablation (RAI), and suppressive therapy with levothyroxine. At 1 year follow-up, the patient was disease free.
conclusionsEven if latest literature reports consider that completion of local surgery with total thyroidectomy and RAI might be too aggressive in cases of MSO without extraovarian extension, in our case it was decided to follow the protocol for primary thyroid carcinoma, in order to reduce the recurrence risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.